Clinical Trial Update: Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects [Phase 2, Phase 3]

View source ↗

Summary

A pilot Phase 2/Phase 3 trial evaluated an epidermal growth factor ointment to manage EGFR-inhibitor–related skin side effects in cancer patients; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• EGF ointment (epidermal growth factor)

Snippet

Sponsor: Dong-A University Hospital | Conditions: Non-small Cell Lung Cancer, Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED